Concurrent Investment Advisors LLC Has $1.43 Million Holdings in Danaher Corporation $DHR

Concurrent Investment Advisors LLC lowered its holdings in Danaher Corporation (NYSE:DHR) by 37.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,207 shares of the conglomerate’s stock after selling 4,252 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Danaher were worth $1,429,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in DHR. WFA of San Diego LLC bought a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Danaher in the 2nd quarter valued at about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter worth $28,000. Tripletail Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at about $31,000. Finally, Red Tortoise LLC increased its position in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $236.05 on Friday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The business has a 50 day moving average price of $228.31 and a 200-day moving average price of $211.85. The company has a market cap of $166.73 billion, a PE ratio of 48.67, a price-to-earnings-growth ratio of 4.27 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue was up 4.4% on a year-over-year basis. During the same period last year, the business posted $1.71 earnings per share. Equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is presently 26.39%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 30,248 shares of company stock valued at $6,609,663 over the last three months. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research report on Thursday, December 18th. Bank of America decreased their price objective on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. The Goldman Sachs Group started coverage on shares of Danaher in a research report on Tuesday, December 9th. They issued a “buy” rating and a $265.00 target price for the company. Morgan Stanley assumed coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Twenty-one analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $250.96.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.